Foghorn Therapeutics Director Ian F. Smith Receives Stock Options Grant

This SEC Form 4 filing reports that Ian F. Smith, a director of Foghorn Therapeutics Inc. (FHTX), was granted 28,000 stock options on June 24, 2026. The options have an exercise price of $4.08 per share and expire on June 23, 2036. According to the filing, the options vest in full on the first anniversary of the grant date, subject to Smith's continued service on the board of directors. The transaction represents an acquisition (Code A) of derivative securities, and following this grant, Smith owns 28,000 stock options in the company. The filing was signed by Michael LaCascia as Attorney-in-Fact for Ian F. Smith on June 25, 2026. This type of equity compensation is common for directors and aligns their interests with those of shareholders.